Can-Fite Reports First Quarter 2023 Financial Results & Provides Clinical Update
PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncology
Source: finanznachrichten.de